Mainstay Medical International plc: Standard Form for Notification of Major Holdings

DUBLIN--()--Regulatory News:

Standard Form TR-1

Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of Ireland)i
 
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Mainstay Medical International plc

2. Reason for the notification (please tick the appropriate box or boxes):

[x] An acquisition or disposal of voting rights

[ ] An acquisition or disposal of financial instruments

[x] An event changing the breakdown of voting rights

[ ] Other (please specify)iii:

3. Details of person subject to the notification obligationiv :
Name: Sofinnova Capital VI FCPR   City and country of registered office (if applicable): N/A

18 rue du 4 Septembre 75002, Paris, France

4. Full name of shareholder(s) (if different from 3.)v: N/A
5. Date on which the threshold was crossed or reachedvi: 15 February 2018
6. Date on which issuer notified: 16 February 2018
7. Threshold(s) that is/are crossed or reached: Below 32%
8. Total positions of person(s) subject to the notification obligation:
    % of voting rights attached to shares (total of 9.A) % of voting rights through financial instruments
(total of 9.B.1 + 9.B.2)
  Total of both in % (9.A + 9.B)   Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 27.5% N/A 27.5% 2,415,813
Position of previous notification (if applicable) 32.7% N/a 32.7%  

9. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii:

A: Voting rights attached to shares
Class/type of
shares

ISIN code (if possible)

  Number of voting rightsix   % of voting rights

Direct

 

Indirect

Direct

 

Indirect

  2,415,813 N/A 27.5% N/A
         
         
SUBTOTAL A 2,415,813   27.5%  
 
B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations
Type of financial instrument   Expiration
datex
  Exercise/
Conversion Periodxi
Number of voting rights that may be acquired if the instrument is exercised/converted.   % of voting rights
N/A N/A N/A N/A N/A
         
         
SUBTOTAL B.1    
 
B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations
Type of financial instrument Expiration
datex
Exercise/
Conversion Period xi
  Physical or cash settlementxii   Number of voting rights % of voting rights
N/A N/A N/A N/A N/A N/A
           
           
SUBTOTAL B.2    
10. Information in relation to the person subject to the notification obligation (please tick the applicable box):

 

[x] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii

 

[ ] Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv:

Namexv   % of voting rights if it equals or is higher than the notifiable threshold   % of voting rights through financial instruments if it equals or is higher than the notifiable threshold   Total of both if it equals or is higher than the notifiable threshold
       
       
       
       
       
 
11. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date]

N/A

 
12. Additional informationxvi:

Sofinnova Partners SAS, a French corporation (“SP SAS”), the management company of Sofinnova

Capital VI FCPR, may be deemed to have sole voting power, and Denis Lucquin, Antoine Papiernik and

Monique Saulnier, the managing partners of SP SAS, may be deemed to have shared power to vote these

shares.

Done at Paris on 16 February 2018.

Contacts

Mainstay Medical International plc

Contacts

Mainstay Medical International plc